JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2004; 44:1786-1791, doi:10.1016/j.jacc.2004.07.052
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Best, P. J.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Best, P. J.M.

PERCUTANEOUS INTERVENTION AND RENAL DYSFUNCTION

Impact of mild or moderate chronic kidney disease on the frequency of restenosis

Results from the PRESTO trial

Patricia J.M. Best, MD*,*, Peter B. Berger, MD{dagger}, Barry R. Davis, MD, PhD{ddagger}, Cindy L. Grines, MD§, H. Mehrdad Sadeghi, MD§, Brent A. Williams, MS*, James T. Willerson, MD||, Jeffrey R. Granett, MD, David R. Holmes, Jr, MD* PRESTO Investigators

* Mayo Clinic, Rochester, Minnesota, USA
{dagger} Duke University, Durham, North Carolina, USA
{ddagger} University of Texas School of Public Health, Houston, Texas, USA
§ William Beaumont Hospital, Royal Oak, Michigan, USA
|| University of Texas Medical School and Texas Heart Institute, Houston, Texas, USA
GlaxoSmithKline, Collegeville, Pennsylvania, USA

Manuscript received February 20, 2004; revised manuscript received July 6, 2004, accepted July 12, 2004.

* Reprint requests and correspondence: Dr. Patricia J. M. Best, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905 (Email: best.patiricia{at}mayo.edu).

OBJECTIVES: The goal of this study was to determine if restenosis is increased in mild and moderate chronic kidney disease (CKD) patients after percutaneous coronary intervention (PCI).

BACKGROUND: Mortality is increased in CKD after PCI. Restenosis may contribute to increased late mortality.

METHODS: We analyzed 11,187 patients with a creatinine <1.8 mg/dl from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial, grouped by estimated creatinine clearance (CrCl) (<60, 60 to 89, >89 ml/min). The Cox proportional hazards models investigated the association between CrCl group and death, myocardial infarction, and target vessel revascularization (TVR). Generalized estimating equation regression models determined the association between CrCl group and lesion-specific restenosis.

RESULTS: At 30 days, there was no difference in myocardial infarction, death, or TVR between the CrCl groups. At nine months, mortality was higher in the lowest CrCl group (2.2%, 1.2%, 0.8%; p < 0.001), which was no longer significant after adjusting for confounding variables. Myocardial infarction and TVR were not different between the groups. In patients undergoing protocol follow-up angiography, restenosis (≥50%) was not increased with CKD (32%, 32%, 37%; p = 0.02).

CONCLUSIONS: Mortality nine months after PCI is mildly increased in mild or moderate CKD patients. However, restenosis is not and does not account for the increased mortality.

Abbreviations and Acronyms
  CABG = coronary artery bypass graft
  CHF = congestive heart failure
  CKD = chronic kidney disease
  CrCl = creatinine clearance
  HR = hazard ratio
  MI = myocardial infarction
  PCI = percutaneous coronary intervention
  PRESTO = Prevention of REStenosis with Tranilast and its Outcomes trial
  TVR = target vessel revascularization




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
D. Charytan, J. P. Forman, and D. E. Cutlip
Risk of target lesion revascularization after coronary stenting in patients with and without chronic kidney disease
Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2578 - 2585.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. S. Hillis, B. H. Cuthbertson, and B. L. Croal
Renal function, revascularization and risk
Eur. Heart J., April 1, 2007; 28(7): 782 - 784.
[Full Text] [PDF]


Home page
QJMHome page
N.C. Edwards, R.P. Steeds, C.J. Ferro, and J.N. Townend
The treatment of coronary artery disease in patients with chronic kidney disease
QJM, November 1, 2006; 99(11): 723 - 736.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2004 by the American College of Cardiology Foundation.